Record ID | marc_loc_2016/BooksAll.2016.part21.utf8:9263122:1148 |
Source | Library of Congress |
Download Link | /show-records/marc_loc_2016/BooksAll.2016.part21.utf8:9263122:1148?format=raw |
LEADER: 01148pam a2200325 a 4500
001 91020144
003 DLC
005 20060728215702.0
008 910531s1991 nyua b 001 0 eng c
010 $a 91020144
020 $a0824784847 (alk. paper)
040 $aDNLM/DLC$cDLC$dDLC
050 10 $aRM301.45$b.P454 1991
060 $aW1 DR893B v. 48$aQV 38 P5315
082 00 $a615.5/8$220
245 00 $aPharmaceutical bioequivalence /$cedited by Peter G. Welling, Francis L.S. Tse, Shrikant V. Dighe.
260 $aNew York :$bDekker,$cc1991.
300 $aix, 467 p. ;$bill. ;$c23 cm.
440 0 $aDrugs and the pharmaceutical sciences ;$vv. 48
504 $aIncludes bibliographical references and index.
650 0 $aDrugs$xTherapeutic equivalency.
650 0 $aDrugs$xBioavailability.
650 2 $aBiological Availability.
650 2 $aDrug Evaluation.
650 2 $aDrugs$xadministration & dosage.
650 2 $aTherapeutic Equivalency.
700 1 $aWelling, Peter G.
700 1 $aTse, Francis L. S.
700 1 $aDighe, Shrikant V.
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0647/91020144-d.html